GPT-4 results in decreased error rate for all tasks with increasing complexity when compared to GPT-3.5-turbo. by Jacqueline A. Jansen (14894276)

Mutational landscape of immune surveillance genes in diffuse large B-cell lymphoma by Marijana Nesic (8771654)

“…It plays a crucial role in controlling the initiation and progression of hematologic cancers such as leukemia and lymphoma, and it has been reported that diffuse large B-cell lymphoma (DLBCL) fails to express specific cell-surface molecules that are necessary for the recognition and elimination of tumor cells.…”

Maps of median projected λ_<i>S</i> (a) and <i>R</i>₀ (b) across 1st-level sub-national administrative regions in selected African countries. by Keith Fraser (1868587)

How replay can hurt. by Georgy Antonov (11938961)

Decreased <i>Bgl-</i>FaNaC expression in the left parietal ganglion following <i>S</i>. <i>mansoni</i> infection. by Laura C. Vicente-Rodríguez (16437803)

“…See values in <a href="http://www.plosntds.org/article/info:doi/10.1371/journal.pntd.0011249#pntd.0011249.t001" target="_blank">Table 1</a>. <b>e-g:</b> Decreased <i>Bgl</i>-FaNaC hybridization on the ventral surface of the left parietal ganglion in infected specimens. …”

Maps of median projected λ_<i>S</i> (a) and <i>R</i>₀ (b) across 1st-level sub-national administrative regions in selected South American countries. by Keith Fraser (1868587)

(a) Top view of NBRFET, (b) cross view of NBRFET along cutting line A in Fig 1(a), (c) cross view of NBRFET along cutting line B in Fig 1(a), (d) top view of along cutting line A i... by Xiaoshi Jin (15675049)

Subjects:

Excreted products from adult STAT6 KO -adapted worms have decreased immunogenicity. by Annabel A. Ferguson (17616286)

Table_1_Mutational Profile and Clonal Evolution of Relapsed/Refractory Diffuse Large B-Cell Lymphoma.xlsx by Boram Lee (549836)

“…The genes most frequently altered (> 20%) were (in decreasing order of frequency) CDKN2A, PIM1, CD79B, TP53, MYD88, MYC, BTG2, BTG1, CDKN2B, DTX1, CD58, ETV6, and IRF4. …”

Modeled concentrations (mg/kg dry weight) of lead (Pb) in <i>Hylocomium splendens</i> moss tissue in 2006 and 2017, average change, percent change, and probability of decrease for... by Peter N. Neitlich (4034300)

Modeled concentrations (mg/kg dry weight) of zinc (Zn) in <i>Hylocomium splendens</i> moss tissue in 2006 and 2017, average change, percent change, and probability of decrease for... by Peter N. Neitlich (4034300)

Modeled concentrations (mg/kg dry weight) of cadmium (Cd) in <i>Hylocomium splendens</i> moss tissue in 2006 and 2017, average change, percent change, and probability of decrease f... by Peter N. Neitlich (4034300)

ΔNp63α over-expression decreases p38 kinase activity, which is required for R mediated lytic reactivation. by Nicholas Van Sciver (8452521)

Table_1_Improvement of Emotional Empathy and Cluster B Personality Disorder Symptoms Associated With Decreased Cocaine Use Severity.docx by Matthias Vonmoos (759842)

“…Moreover, whereas decreased cocaine use was associated with reduced severity of self-reported cluster B PD symptoms, these symptoms remained largely stable in increasers. …”

<i>N</i>. <i>bombycis</i> coated with Vg in the ovarioles of <i>S</i>. <i>litura</i> and <i>H</i>. <i>armigera</i>. by Chunxia Wang (766713)

Subjects:

Benefit maps of combination therapy with ADT. by Nourridine Siewe (5081834)

Average self-reported physical health ratings before or during the COVID-19 pandemic among individuals who engaged during the pandemic in more than 3 (A), 4 (B), or 5 (C) positive... by Elie Mulhem (22537863)

Subjects:

DataSheet_1_Nonclassical Monocytes Are Prone to Migrate Into Tumor in Diffuse Large B-Cell Lymphoma.docx by Simon Le Gallou (10742601)

“…<p>Absolute count of circulating monocytes has been proposed as an independent prognostic factor in diffuse large B-cell lymphoma (DLBCL). However, monocyte nomenclature includes various subsets with pro-, anti-inflammatory, or suppressive functions, and their clinical relevance in DLBCL has been poorly explored. …”

Antibody and antigen responses to Ensovibep vs placebo day 1–90. by Elizabeth S. Munroe (21568166)

Subjects:

Antibody and antigen responses to Lufotrelvir vs placebo day 1–90. by Elizabeth S. Munroe (21568166)

Subjects: